Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
- Grande, E.
- Rodriguez-Antona, C.
- López, C.
- Alonso-Gordoa, T.
- Benavent, M.
- Capdevila, J.
- Teulé, A.
- Custodio, A.
- Sevilla, I.
- Hernando, J.
- Gajate, P.
- Molina-Cerrillo, J.
- Díez, J.J.
- Santos, M.
- Lanillos, J.
- García-Carbonero, R.
ISSN: 1549-490X, 1083-7159
Year of publication: 2021
Volume: 26
Issue: 11
Pages: 941-949
Type: Article